The University of Southampton
University of Southampton Institutional Repository

NAFLD: A multisystem disease

NAFLD: A multisystem disease
NAFLD: A multisystem disease
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries that is predicted to become also the most frequent indication for liver transplantation by 2030. Over the last decade, it has been shown that the clinical burden of NAFLD is not only confined to liver-related morbidity and mortality, but there is now growing evidence that NAFLD is a multisystem disease, affecting extra-hepatic organs and regulatory pathways. For example, NAFLD increases risk of type 2 diabetes mellitus (T2DM), cardiovascular (CVD) and cardiac diseases, and chronic kidney disease (CKD). Although the primary liver pathology in NAFLD affects hepatic structure and function to cause morbidity and mortality from cirrhosis, liver failure and hepatocellular carcinoma, the majority of deaths among NAFLD patients are attributable to CVD. This narrative review focuses on the rapidly expanding body of clinical evidence that supports the concept of NAFLD as a multisystem disease. The review discusses the factors involved in the progression of liver disease in NAFLD and the factors linking NAFLD with other extra-hepatic chronic diseases, such as T2DM, CVD, cardiac diseases and CKD. The review will not discuss NAFLD treatments as these are discussed elsewhere in this issue of the Journal. For this review, PubMed was searched for articles using the keywords “non-alcoholic fatty liver disease” or “fatty liver” combined with “diabetes”, “cardiovascular (or cardiac) disease”, “cardiovascular mortality” or “chronic kidney disease” between 1990 and 2014. Articles published in languages other than English were excluded.
non-alcoholic fatty liver disease, hepatocellular carcinoma, type 2 diabetes, insulin resistance, cardiovascular disease, cardiac disease, cardiac arrhythmias, chronic kidney disease
0168-8278
S47-S64
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Targher, Giovanni
0ff043ec-7e91-4a17-a7fc-648586077a8a
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Targher, Giovanni
0ff043ec-7e91-4a17-a7fc-648586077a8a

Byrne, Christopher D. and Targher, Giovanni (2015) NAFLD: A multisystem disease. [in special issue: Emerging Trends in Hepatology] Journal of Hepatology, 62 (1), S47-S64. (doi:10.1016/j.jhep.2014.12.012). (PMID:25920090)

Record type: Article

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries that is predicted to become also the most frequent indication for liver transplantation by 2030. Over the last decade, it has been shown that the clinical burden of NAFLD is not only confined to liver-related morbidity and mortality, but there is now growing evidence that NAFLD is a multisystem disease, affecting extra-hepatic organs and regulatory pathways. For example, NAFLD increases risk of type 2 diabetes mellitus (T2DM), cardiovascular (CVD) and cardiac diseases, and chronic kidney disease (CKD). Although the primary liver pathology in NAFLD affects hepatic structure and function to cause morbidity and mortality from cirrhosis, liver failure and hepatocellular carcinoma, the majority of deaths among NAFLD patients are attributable to CVD. This narrative review focuses on the rapidly expanding body of clinical evidence that supports the concept of NAFLD as a multisystem disease. The review discusses the factors involved in the progression of liver disease in NAFLD and the factors linking NAFLD with other extra-hepatic chronic diseases, such as T2DM, CVD, cardiac diseases and CKD. The review will not discuss NAFLD treatments as these are discussed elsewhere in this issue of the Journal. For this review, PubMed was searched for articles using the keywords “non-alcoholic fatty liver disease” or “fatty liver” combined with “diabetes”, “cardiovascular (or cardiac) disease”, “cardiovascular mortality” or “chronic kidney disease” between 1990 and 2014. Articles published in languages other than English were excluded.

Other
1-s2.0-S0168827814009337-main.pdf__tid=acb7aa8a-f8af-11e4-9175-00000aacb360&acdnat=1431439592_e331abb71e46a0c2378dba7b355b6c42 - Version of Record
Download (1MB)

More information

Published date: April 2015
Keywords: non-alcoholic fatty liver disease, hepatocellular carcinoma, type 2 diabetes, insulin resistance, cardiovascular disease, cardiac disease, cardiac arrhythmias, chronic kidney disease
Organisations: Human Development & Health

Identifiers

Local EPrints ID: 376689
URI: https://eprints.soton.ac.uk/id/eprint/376689
ISSN: 0168-8278
PURE UUID: e269853d-23f1-4a49-b644-77f9f53592b1
ORCID for Christopher D. Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 12 May 2015 14:06
Last modified: 06 Jun 2018 12:54

Export record

Altmetrics

Contributors

Author: Giovanni Targher

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×